Kiniksa Pharmaceuticals International Plc (KNSA)
45.31
+0.60
(+1.34%)
USD |
NASDAQ |
Feb 13, 16:00
45.79
+0.48
(+1.06%)
After-Hours: 16:23
Kiniksa Pharmaceuticals International Market Cap : 3.434B for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 24.01M |
| NovoCure Ltd. | 1.230B |
| LivaNova Plc | 3.595B |
| ADMA Biologics, Inc. | 3.822B |
| Alterola Biotech, Inc. | 7.444M |
Market Cap Related Metrics
| PE Ratio | 101.07 |
| PS Ratio | 5.805 |
| Price to Book Value | 6.415 |
| Price to Free Cash Flow | 34.12 |
| Price | 45.31 |
| Earnings Yield | 0.99% |
| Operating PE Ratio | 90.98 |
| Normalized PE Ratio | 101.05 |